1 / 4

Subcutaneous Drug Delivery Devices Market Worth $46.6 Billion By 2027 - Cost and Profit Status

The global subcutaneous drug delivery devices market size is anticipated to value USD 46.6 billion until 2027. It is also expected to register a CAGR of 10.4% over the forecasted years, 2020 to 2027.

Download Presentation

Subcutaneous Drug Delivery Devices Market Worth $46.6 Billion By 2027 - Cost and Profit Status

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Subcutaneous Drug Delivery Devices Market Worth $46.6 Billion By 2027 - Cost and Profit Status “The global subcutaneous drug delivery devices market size is anticipated to value USD 46.6 billion until 2027. It is also expected to register a CAGR of 10.4% over the forecasted years, 2020 to 2027. The need for reducing needle injuries and surging prevalence of self-administrative drug delivery is projected to propel the market growth.” Global Subcutaneous Drug Delivery Devices Market report offers the latest industry trends, technological alteration and forecast data. A deep-dive view of Subcutaneous Drug Delivery Devices industry based on its size, growth, development plans, and opportunities is offered by this report. The forecast information, SWOT analysis, Subcutaneous Drug Delivery Devices barriers, and feasibility study are the vital aspects evaluated in this report. The global subcutaneous drug delivery devices market size is anticipated to value USD 46.6 billion until 2027. It is also expected to register a CAGR of 10.4% over the forecasted years, 2020 to 2027. The need for reducing needle injuries and surging prevalence of self-administrative drug delivery is projected to propel the market growth. The pen injectors product segment dominated the global market due to the increasing number of product approvals, affordability and higher social acceptance. On the other hand, the wearable injectors segment is anticipated to register the highest CAGR in the upcoming years due to their feature of administrating higher-volume and viscosity biological drugs. In 2019, the segment of retail pharmacies dominated the global market with a 44.9% share on account of increasing self- administration and rising patient awareness across this region. The online pharmacies segment accounted for the highest CAGR across the global market in the upcoming years on account of discounts and offers provided by the vendors over the online purchase. Request Sample Copy of This Market Research @ https://www.millioninsights.com/industry-reports/global-subcutaneous-drug-delivery-devices-market/request-sample

  2. North America accounted for the highest share of around 44.1% across the global subcutaneous drug delivery devices market in 2019 due to the increasing number of investments in the healthcare sector in the U.S. and Canada. The Asia Pacific is anticipated to register substantial growth in the upcoming years due to the rising number of diabetic patients across countries like India and China. The market across the globe includes key players such as Ypsomed AG, Gerresheimer AG, Insulet Corporation, Unilife Corporation, PharmaJet, and Elcam Medical Group. Rapid technological developments and product innovations are undertaken by these players to gain a cutting edge over other players. Browse Full Research Report @ https://www.millioninsights.com/industry-reports/global-subcutaneous-drug-delivery-devices-market Further key findings from the report suggest: • In 2019, the pen injectors segment dominated the global market. • The online pharmacies segment accounted for the highest CAGR across the global market from 2020 to 2027. • North America accounted for the highest share of around 44.1% across the global market in 2019. • The key players operating in this market areYpsomed AG, Gerresheimer AG, Insulet Corporation, Unilife Corporation, PharmaJet, and Elcam Medical Group. Million Insights has segmented the global subcutaneous drug delivery devices market on the basis of product, distribution channel and region: Subcutaneous Drug Delivery Devices Product Outlook (Revenue, USD Million, 2016 - 2027) • Prefilled syringes • Pen injectors

  3. • Auto-injectors • Wearable injectors • Needle-free injectors Subcutaneous Drug Delivery Devices Distribution Channel Outlook (Revenue, USD Million, 2016 - 2027) • Hospital pharmacies • Retail pharmacies • Online pharmacies Subcutaneous Drug Delivery Devices Regional Outlook (Revenue, USD Million, 2016 - 2027) • North America • The U.S. • Canada • Europe • The U.K. • Germany • France • Italy • Spain • Asia Pacific • Japan • China • India • South Korea • Australia • Latin America • Brazil • Mexico • Argentina • Colombia • Middle East & Africa • South Africa

  4. • Saudi Arabia • UAE See More Reports of this Category by Million Insights @ https://www.millioninsights.com/industry/medical-devices Get in touch At Million Insights, we work with the aim to reach the highest levels of customer satisfaction. Our representatives strive to understand diverse client requirements and cater to the same with the most innovative and functional solutions. Contact Person: Ryan Manuel Research Support Specialist, USA Email: ryan@millioninsights.com Global Headquarters Million Insights 410 E Santa Clara Street, Unit #1008 San Jose,CA 95113, United States Phone: 1-408-610-2300 Email: sales@millioninsights.com Asia Pacific Million Insights Office No. 302, 3rd Floor, Manikchand Galleria, Model Colony, Shivaji Nagar, Pune, MH, 411016 India Phone: 91-8956380892

More Related